Pfleger Langzeit-Follow-up-Daten zur nonavalenten HPV-Impfung — Die meisten sexuell aktiven Männer und Frauen infizieren sich im Laufe ihres Lebens mit humanen Papillomviren (HPV). Bei den meisten Menschen heilt die Infektion mit HPV von selbst aus, aber bei denjenigen, bei denen das ...
a拆下脱粒链罩壳与皮带罩壳,内侧有振动筛的清扫口盖 Dismantles the seed extraction chain lagging and the leather belt lagging, the inside has the shaker to sweep clear the opercule [translate] anonavalent nonavalent [translate] 英语翻译 日语翻译 韩语翻译 德语翻译 法语翻译 俄语翻译 阿拉伯语翻译 ...
Recently, the "recombinant human papillomavirus nonavalent virus-like particle vaccine (hereinafter referred to as "9-valent HPV vaccine") (6, 11, 16, 18, 31, 33, 45, 52, 58 type L1 protein) (Pichia pastoris), developed by Shanghai Zerun Biotechnology Co., Ltd. (hereinafter referred to ...
Abbreviations: 4vHPV, quadrivalent HPV vaccine; 2vHPV, bivalent HPV vaccine; 9vHPV, nonavalent HPV vaccine; FDA, The U.S. Food and Drug Administration; HPV, human papillomavirus; EU, European Union; VLP, virus-like particle. Display full size Figure 2Countries that have introduced a national ...
In women vaccinated with the nonavalent vaccine, only primary HPV testing was efficient, involving decreased frequency (ie, every 10 years) starting at ... JJ Kim,EA Burger,S Stephen,... - 《Jnci Journal of the National Cancer Institute》 被引量: 15发表: 2016年 HPV vaccination and the ef...
Consequently, as we evaluate the cost-benefit and cost-effectiveness of routine female adolescent nonavalent HPV vaccination for Hong Kong, we will also be simultaneously characterizing the underlying assortativity of heterosexual mixing, which in itself is an important knowledge gap on sexually ...
Background A bivalent human papillomavirus vaccine (2vHPV) is currently used in the Netherlands; a nonavalent vaccine (9vHPV) is also licensed.Research design and methods We compared the public health and economic benefits of 2vHPV- and 9vHPV-based vaccination strategies in the Netherlands over ...
本研究开发出一套完整的样品前处理流程,包括从铝佐剂中解吸HPV L1蛋白以及蛋白质的胰蛋白酶酶解,从而通过特征性肽段分析方法定量GARDASIL 9 HPV L1抗原。此工作流程包括质谱分析,能够以高重现性定量10~200 μg/mL范围内的肽段,该范围完全涵盖GARDASIL 9疫苗产品中预...